ARI0003: Clinical Trials

1 trial of ARI0003, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Not yet recruiting 1

Follow ARI0003: new trials by email Literature Review of ARI0003 trials Research Report on ARI0003

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma
ARI0003 - Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma
Early Phase 1Not yet recruitingFundacion Clinic per a la Recerca Biomédica402024-01-152023-10-26

Conditions studied

Lymphoma, Non-Hodgkin (1)

Sponsors

Fundacion Clinic per a la Recerca Biomédica (1)

Countries

Spain (1)

Results publications

PMID 39563035